Poseida Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net

Poseida Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net

Poseida Therapeutics, Inc. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.

Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet · last filed 2021-03-11

• Poseida Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net for fiscal 2020 was $0.00.
• Poseida Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net for fiscal 2019 was $0.00.